Susquehanna Maintains Neutral on Genpact, Lowers Price Target to $37

Benzinga Newsdesk www.benzinga.com Negative 86.0%

Neg 86% Neu 0% Pos 0%

Susquehanna analyst James Friedman maintains Genpact (NYSE:G) with a Neutral and lowers the price target from $42 to $37.